Sanofi insider trades
Sanofi has filed 4 Form 4s with the SEC that we hold, for Attovia Therapeutics, Inc. (ATTO) (10% owner), ICVX (10% owner), Latigo Biotherapeutics, Inc. (LTGO) (10% owner) and TBIO (10% owner). Across all of them we count 4 purchases worth $2.7B and 0 sales worth $0 reported on Form 4. In the last 12 months: 1 purchase ($5.1M) and 0 sales ($0). The largest single trade was a purchase of 51,467,612 shares of TBIO worth $2.0B, dated 2021-09-14. The first filing on our record is dated 2021-08-02 and the latest 2026-08-12.
Attovia Therapeutics, Inc. (ATTO)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2026-08-06 | P, purchase reported on Form 4 | 300,000 | $5.1M | 2026-08-07 |
ICVX
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-08-02 | P, purchase reported on Form 4 | 66,667 | $1.0M | 2021-08-02 |
Latigo Biotherapeutics, Inc. (LTGO)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
TBIO
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-09-14 | P, purchase reported on Form 4 | 20,515,985 | $779.6M | 2021-09-14 |
| 2021-09-14 | P, purchase reported on Form 4 | 51,467,612 | $2.0B | 2021-09-14 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1121404) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms